Literature DB >> 20971953

Patient-derived C-terminal mutation of FANCI causes protein mislocalization and reveals putative EDGE motif function in DNA repair.

Luca Colnaghi1, Mathew J K Jones, Xiomaris M Cotto-Rios, Detlev Schindler, Helmut Hanenberg, Tony T Huang.   

Abstract

Fanconi anemia (FA) is a rare familial genome instability syndrome caused by mutations in FA genes that results in defective DNA crosslink repair. Activation of the FA pathway requires the FA core ubiquitin ligase complex-dependent monoubiquitination of 2 interacting FA proteins, FANCI and FANCD2. Although loss of either FANCI or FANCD2 is known to prevent monoubiquitination of its respective partner, it is unclear whether FANCI has any additional domains that may be important in promoting DNA repair, independent of its monoubiquitination. Here, we focus on an FA-I patient-derived FANCI mutant protein, R1299X (deletion of 30 residues from its C-terminus), to characterize important structural region(s) in FANCI that is required to activate the FA pathway. We show that, within this short 30 amino acid stretch contains 2 separable functional signatures, a nuclear localization signal and a putative EDGE motif, that is critical for the ability of FANCI to properly monoubiquitinate FANCD2 and promote DNA crosslink resistance. Our study enable us to conclude that, although proper nuclear localization of FANCI is crucial for robust FANCD2 monoubiquitination, the putative FANCI EDGE motif is important for DNA crosslink repair.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20971953      PMCID: PMC3062332          DOI: 10.1182/blood-2010-07-295758

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  49 in total

1.  The DNA helicase BRIP1 is defective in Fanconi anemia complementation group J.

Authors:  Marieke Levitus; Quinten Waisfisz; Barbara C Godthelp; Yne de Vries; Shobbir Hussain; Wouter W Wiegant; Elhaam Elghalbzouri-Maghrani; Jûrgen Steltenpool; Martin A Rooimans; Gerard Pals; Fré Arwert; Christopher G Mathew; Małgorzata Z Zdzienicka; Kevin Hiom; Johan P De Winter; Hans Joenje
Journal:  Nat Genet       Date:  2005-08-21       Impact factor: 38.330

2.  The BRCA1-interacting helicase BRIP1 is deficient in Fanconi anemia.

Authors:  Orna Levran; Claire Attwooll; Rashida T Henry; Kelly L Milton; Kornelia Neveling; Paula Rio; Sat Dev Batish; Reinhard Kalb; Eunike Velleuer; Sandra Barral; Jurg Ott; John Petrini; Detlev Schindler; Helmut Hanenberg; Arleen D Auerbach
Journal:  Nat Genet       Date:  2005-08-21       Impact factor: 38.330

3.  FAN1 acts with FANCI-FANCD2 to promote DNA interstrand cross-link repair.

Authors:  Ting Liu; Gargi Ghosal; Jingsong Yuan; Junjie Chen; Jun Huang
Journal:  Science       Date:  2010-07-29       Impact factor: 47.728

Review 4.  Susceptibility pathways in Fanconi's anemia and breast cancer.

Authors:  Alan D D'Andrea
Journal:  N Engl J Med       Date:  2010-05-20       Impact factor: 91.245

5.  Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis.

Authors:  Marzena Bienko; Catherine M Green; Nicola Crosetto; Fabian Rudolf; Grzegorz Zapart; Barry Coull; Patricia Kannouche; Gerhard Wider; Matthias Peter; Alan R Lehmann; Kay Hofmann; Ivan Dikic
Journal:  Science       Date:  2005-12-16       Impact factor: 47.728

6.  Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.

Authors:  Alfons Meindl; Heide Hellebrand; Constanze Wiek; Verena Erven; Barbara Wappenschmidt; Dieter Niederacher; Marcel Freund; Peter Lichtner; Linda Hartmann; Heiner Schaal; Juliane Ramser; Ellen Honisch; Christian Kubisch; Hans E Wichmann; Karin Kast; Helmut Deissler; Christoph Engel; Bertram Müller-Myhsok; Kornelia Neveling; Marion Kiechle; Christopher G Mathew; Detlev Schindler; Rita K Schmutzler; Helmut Hanenberg
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

7.  A genetic screen identifies FAN1, a Fanconi anemia-associated nuclease necessary for DNA interstrand crosslink repair.

Authors:  Agata Smogorzewska; Rohini Desetty; Takamune T Saito; Michael Schlabach; Francis P Lach; Mathew E Sowa; Alan B Clark; Thomas A Kunkel; J Wade Harper; Monica P Colaiácovo; Stephen J Elledge
Journal:  Mol Cell       Date:  2010-07-09       Impact factor: 17.970

8.  Deficiency of FANCD2-associated nuclease KIAA1018/FAN1 sensitizes cells to interstrand crosslinking agents.

Authors:  Katja Kratz; Barbara Schöpf; Svenja Kaden; Ataman Sendoel; Ralf Eberhard; Claudio Lademann; Elda Cannavó; Alessandro A Sartori; Michael O Hengartner; Josef Jiricny
Journal:  Cell       Date:  2010-07-09       Impact factor: 41.582

9.  Heterogeneous activation of the Fanconi anemia pathway by patient-derived FANCA mutants.

Authors:  Daiki Adachi; Tsukasa Oda; Hiroshi Yagasaki; Keiko Nakasato; Toshiyasu Taniguchi; Alan D D'Andrea; Shigetaka Asano; Takayuki Yamashita
Journal:  Hum Mol Genet       Date:  2002-12-01       Impact factor: 6.150

10.  Identification of KIAA1018/FAN1, a DNA repair nuclease recruited to DNA damage by monoubiquitinated FANCD2.

Authors:  Craig MacKay; Anne-Cécile Déclais; Cecilia Lundin; Ana Agostinho; Andrew J Deans; Thomas J MacArtney; Kay Hofmann; Anton Gartner; Stephen C West; Thomas Helleday; David M J Lilley; John Rouse
Journal:  Cell       Date:  2010-07-09       Impact factor: 41.582

View more
  12 in total

Review 1.  The Fanconi anemia ID2 complex: dueling saxes at the crossroads.

Authors:  Rebecca A Boisvert; Niall G Howlett
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

2.  ATR-mediated phosphorylation of FANCI regulates dormant origin firing in response to replication stress.

Authors:  Yu-Hung Chen; Mathew J K Jones; Yandong Yin; Sarah B Crist; Luca Colnaghi; Robert J Sims; Eli Rothenberg; Prasad V Jallepalli; Tony T Huang
Journal:  Mol Cell       Date:  2015-04-02       Impact factor: 17.970

Review 3.  The Fanconi anemia pathway in replication stress and DNA crosslink repair.

Authors:  Mathew J K Jones; Tony T Huang
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

4.  Novel FANCI mutations in Fanconi anemia with VACTERL association.

Authors:  Sharon A Savage; Bari J Ballew; Neelam Giri; Settara C Chandrasekharappa; Najim Ameziane; Johan de Winter; Blanche P Alter
Journal:  Am J Med Genet A       Date:  2015-11-21       Impact factor: 2.802

5.  Fanconi anemia protein FANCI functions in ribosome biogenesis.

Authors:  Samuel B Sondalle; Simonne Longerich; Lisa M Ogawa; Patrick Sung; Susan J Baserga
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-28       Impact factor: 11.205

6.  APC/CCdh1-dependent proteolysis of USP1 regulates the response to UV-mediated DNA damage.

Authors:  Xiomaris M Cotto-Rios; Mathew J K Jones; Luca Busino; Michele Pagano; Tony T Huang
Journal:  J Cell Biol       Date:  2011-07-18       Impact factor: 10.539

7.  FANCI functions as a repair/apoptosis switch in response to DNA crosslinks.

Authors:  Richa B Shah; Jennifer L Kernan; Anya van Hoogstraten; Kiyohiro Ando; Yuanyuan Li; Alicia L Belcher; Ivy Mininger; Andrei M Bussenault; Renuka Raman; Ramanagouda Ramanagoudr-Bhojappa; Tony T Huang; Alan D D'Andrea; Settara C Chandrasekharappa; Aneel K Aggarwal; Ruth Thompson; Samuel Sidi
Journal:  Dev Cell       Date:  2021-07-12       Impact factor: 13.417

8.  FANCI Regulates Recruitment of the FA Core Complex at Sites of DNA Damage Independently of FANCD2.

Authors:  Maria Castella; Celine Jacquemont; Elizabeth L Thompson; Jung Eun Yeo; Ronald S Cheung; Jen-Wei Huang; Alexandra Sobeck; Eric A Hendrickson; Toshiyasu Taniguchi
Journal:  PLoS Genet       Date:  2015-10-02       Impact factor: 5.917

Review 9.  Update of the human and mouse Fanconi anemia genes.

Authors:  Hongbin Dong; Daniel W Nebert; Elspeth A Bruford; David C Thompson; Hans Joenje; Vasilis Vasiliou
Journal:  Hum Genomics       Date:  2015-11-24       Impact factor: 4.639

10.  Coordinate nuclear targeting of the FANCD2 and FANCI proteins via a FANCD2 nuclear localization signal.

Authors:  Rebecca A Boisvert; Meghan A Rego; Paul A Azzinaro; Maurizio Mauro; Niall G Howlett
Journal:  PLoS One       Date:  2013-11-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.